CLU and lipoprotein glomerulopathy: CLU, a secreted protein which originates from multiple segments of the renal tubule as well as mesangial cells, increased in urine on days 16, 21, and 28 in anti-Fx1A-treated animals, consistent with previous rat models of glomerulopathy [30, 37].